Osteopontin Identified as Lead Marker of Colon Cancer Progression, Using Pooled Sample Expression Profiling

Abstract

Sample pooling can be a powerful, cost-effective, and rapid means of identifying the most common changes in a gene expression profile. We identified osteopontin as a clinically useful marker of tumor progression by use of gene expression profiling on pooled samples.